HealthIndiaCOVID-19Ministry of Health and Family Welfare

India’s Cumulative COVID-19 Vaccination Coverage exceeds 176.19 Cr

More than 33.84 lakh Vaccine Doses administered in the last 24 hours

Recovery Rate currently stands at 98.42%

15,102 New Cases reported in the last 24 hours

India’s Active Caseload currently stands at 1,64,522

Weekly Positivity Rate is presently at 1.80%

With the administration of more than 33.84 lakh Doses (33,84,744) vaccine doses in the last 24 hours, India’s COVID-19 vaccination coverage has exceeded 176.19 Cr (1,76,19,39,020) as per provisional reports till 7 am today.

This has been achieved through 2,00,89,198 sessions. The break-up of the cumulative figure as per the provisional report till 7 am today include:

Cumulative Vaccine Dose Coverage
HCWs 1st Dose 1,04,00,989
2nd Dose 99,57,566
Precaution Dose 40,92,955
FLWs 1st Dose 1,84,08,453
2nd Dose 1,74,25,974
Precaution Dose 60,07,839
Age Group 15-18 years 1st Dose 5,40,95,926
2nd Dose 2,38,74,286
Age Group 18-44 years 1st Dose 55,08,71,373
2nd Dose 43,87,03,109
Age Group 45-59 years 1st Dose 20,21,21,033
2nd Dose 17,89,56,844
Over 60 years 1st Dose 12,62,84,159
2nd Dose 11,14,80,545
Precaution Dose 92,57,969
Precaution Dose 1,93,58,763
Total 1,76,19,39,020

 

31,377 patients have recovered in the last 24 hours and the cumulative tally of recovered patients (since the beginning of the pandemic) is now at 4,21,89,887.

Consequently, India’s recovery rate stands at 98.42%.

15,102 new cases were reported in the last 24 hours.

 

India’s Active Caseload is presently at 1,64,522. Active cases constitute 0.38% of the country’s total Positive Cases.

 

The testing capacity across the country continues to be expanded. The last 24 hours saw a total of 11,83,438 tests being conducted. India has so far conducted over 76.24 Cr (76,24,14,018) cumulative tests.

While testing capacity has been enhanced across the country, Weekly Positivity Rate in the country currently stands at 1.80% and the Daily Positivity rate is reported to be 1.28%.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Comment moderation is enabled. Your comment may take some time to appear.

Back to top button

Adblock detected

Please consider supporting us by disabling your ad blocker